Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study-Reference-Cited by-同舟云学术

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

Published:2015-11 Issue:15 Volume:16 Page:1547-1555
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Jabbour Elias,Kantarjian Hagop,Ravandi Farhad,Thomas Deborah,Huang Xuelin,Faderl Stefan,Pemmaraju Naveen,Daver Naval,Garcia-Manero Guillermo,Sasaki Koji,Cortes Jorge,Garris Rebecca,Yin C Cameron,Khoury Joseph D,Jorgensen Jeffrey,Estrov Zeev,Bohannan Zachary,Konopleva Marina,Kadia Tapan,Jain Nitin,DiNardo Courtney,Wierda William,Jeanis Vicky,O'Brien Susan

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia;Fielding;Blood,2014

2. First report of phase II study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia;Ravandi;Blood,2010

3. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study;Schultz;J Clin Oncol,2009

4. Long-term outcome after hyper-CVA and imatinib (IM) for de novo or minimally treated Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-ALL);Thomas;Proc Am Soc Clin Oncol,2010

5. Long-term follow up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study;Tanguy-Schmidt;Biol Blood Marrow Transplant,2013

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL;Journal of Clinical Oncology;2024-07-19

3. SOHO State of the Art Updates and Next Questions | Next Questions: Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-06

4. Efficacy of Chemotherapy-Free Regimens in the Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2024-06

5. Ponatinib‐review of historical development, current status, and future research;American Journal of Hematology;2024-05-10